BioNeutra Global Corporation
BGACF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $11,383 | $13,391 | $15,401 | $24,116 |
| % Growth | -15% | -13.1% | -36.1% | – |
| Cost of Goods Sold | $7,240 | $11,042 | $12,510 | $20,172 |
| Gross Profit | $4,143 | $2,348 | $2,891 | $3,944 |
| % Margin | 36.4% | 17.5% | 18.8% | 16.4% |
| R&D Expenses | $146 | -$16 | $12 | $257 |
| G&A Expenses | $3,729 | $3,781 | $3,732 | $3,955 |
| SG&A Expenses | $4,123 | $3,922 | $4,166 | $4,317 |
| Sales & Mktg Exp. | $394 | $141 | $434 | $361 |
| Other Operating Expenses | $1,293 | $909 | $1,068 | $2,397 |
| Operating Expenses | $5,581 | $4,815 | $5,246 | $6,970 |
| Operating Income | -$1,438 | -$2,418 | -$2,355 | -$3,026 |
| % Margin | -12.6% | -18.1% | -15.3% | -12.5% |
| Other Income/Exp. Net | -$669 | -$455 | -$474 | -$745 |
| Pre-Tax Income | -$2,108 | -$2,921 | -$2,830 | -$3,772 |
| Tax Expense | $0 | $0 | $0 | -$65 |
| Net Income | -$2,108 | -$2,921 | -$2,830 | -$3,707 |
| % Margin | -18.5% | -21.8% | -18.4% | -15.4% |
| EPS | -0.05 | -0.063 | -0.061 | -0.08 |
| % Growth | 20.5% | -3.3% | 23.9% | – |
| EPS Diluted | -0.045 | -0.063 | -0.061 | -0.08 |
| Weighted Avg Shares Out | 46,449 | 46,449 | 46,449 | 46,449 |
| Weighted Avg Shares Out Dil | 46,449 | 46,449 | 46,449 | 46,449 |
| Supplemental Information | – | – | – | – |
| Interest Income | $118 | $0 | $3 | $4 |
| Interest Expense | $697 | $450 | $391 | $433 |
| Depreciation & Amortization | $1,058 | $1,111 | $1,324 | $1,841 |
| EBITDA | -$352 | -$1,360 | -$1,115 | -$1,498 |
| % Margin | -3.1% | -10.2% | -7.2% | -6.2% |